Centenial Surgical Suture Ltd vs Tarsons Products Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Centenial Surgical Suture Ltd is ₹ 67.95 as of 23 Oct 15:30 . The P/E Ratio of Centenial Surgical Suture Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Tarsons Products Ltd changed from 37.2 on March 2022 to 62 on March 2026 . This represents a CAGR of 13.62% over 4 years The Market Cap of Centenial Surgical Suture Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Tarsons Products Ltd changed from ₹ 3746 crore on March 2022 to ₹ 887.21 crore on March 2026 . This represents a CAGR of -30.24% over 4 years The revenue of Centenial Surgical Suture Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Tarsons Products Ltd for the Jun '26 is ₹ 116.22 crore as compare to the Mar '26 revenue of ₹ 127.76 crore. This represent the decline of -9.03% The ebitda of Centenial Surgical Suture Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Tarsons Products Ltd for the Jun '26 is ₹ 31.96 crore as compare to the Mar '26 ebitda of ₹ 41.1 crore. This represent the decline of -22.24% The net profit of Centenial Surgical Suture Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The net profit of Tarsons Products Ltd changed from ₹ 4.02 crore to ₹ -1.44 crore over 9 quarters. This represents a CAGR of NaN% The Dividend Payout of Centenial Surgical Suture Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Tarsons Products Ltd changed from 20.76 % on March 2024 to 0 % on March 2026 . This represents a CAGR of -100.00% over 3 years .

About Centenial Surgical Suture Ltd

Incorporated in 1995, Centenial Surgical Suture Limited is engaged in the manufacture and sale of surgical sutures in India.
The company offers absorbable sutures that include natural and synthetic sutures and non absorbable sutures comprising needles for cardiovascular surgery, monofilament polyamide atraumatic needle suture combinations, monofilament stainless steel, and temporary pacemaker electrodes.
It also provides female urinary incontinency sets, titanium haemostatic clips for cardiovascular surgery, non absorbable. Company leverages the expertise and application knowledge of the global suture requirements for cardiovascular sutures in particular, to bring advanced atraumatic needle product development to the Indian Surgeons.
Continuous innovation in the areas of design, research and development of atraumatic needle, simulation and validation, testing and services, are the key value creation driver for the Company.

About Tarsons Products Ltd

Tarsons Products Limited was incorporated as Tarsons Products Private Limited on July 5, 1983.
The Company was subsequently converted into a Public Limited Company and the name of the Company was changed to Tarsons Products Limited on June 14, 2021. Tarsons is an Indian labware Company engaged in designing, developing, manufacturing and marketing of consumables', reusables' and others' (including benchtop equipment), used in various laboratories across research organizations, academia institutes, pharmaceutical companies, CROs, diagnostic companies and hospitals.
The Company is also engaged in the manufacturing of wide range of quality labware products which helps scientific discovery and improve healthcare.
Tarsons currently operate through five manufacturing facilities located in West Bengal.

FAQs for the comparison of Centenial Surgical Suture Ltd and Tarsons Products Ltd

Which company has a larger market capitalization, Centenial Surgical Suture Ltd or Tarsons Products Ltd?

Market cap of Centenial Surgical Suture Ltd is 24 Cr while Market cap of Tarsons Products Ltd is 1,595 Cr

What are the key factors driving the stock performance of Centenial Surgical Suture Ltd and Tarsons Products Ltd?

The stock performance of Centenial Surgical Suture Ltd and Tarsons Products Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Centenial Surgical Suture Ltd and Tarsons Products Ltd?

As of October 25, 2026, the Centenial Surgical Suture Ltd stock price is INR ₹67.95. On the other hand, Tarsons Products Ltd stock price is INR ₹299.95.

How do dividend payouts of Centenial Surgical Suture Ltd and Tarsons Products Ltd compare?

To compare the dividend payouts of Centenial Surgical Suture Ltd and Tarsons Products Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.